eribulin mesylate
eisai
['halaven', 'eribulin', 'eisai']
eisai presents results of post-hoc analysis of eribulin mesylate (halaven ) at the european society for medical oncology (esmo) congress 2022
este e sunbios provisional pero debemos de buscar uno bueno